+977-1-4221512 / 4250794

Objectives

The primary objective of the company was to manufacture various pharmaceutical dosage forms to meet requirements of the nation. In specific the company aimed: To manufacture allopathic medicines for the requirement of the country To carry out quality control of imported products To contribute for the quality assurance of the marketed products To supply medicine to the general public in an affordable price To play vital role by substituting import...

Learn More
About us

Nepal Aushadhi Limited

"A PIONEER PHARMACEUTICAL INDUSTRY OF NEPAL" Nepal Aushadhi Limited a government enterprise established in 2029 under the company Act, 2021 with the help of technical collaboration of the British Government in the form of expertise & equipment, and become a milestone in the pharmaceutical industry of the nation. The company was an extension of Formulation Unit of Royal Drug Research Laboratory (now National Medicine Laboratory under Department of Drug Administration) which was under Department of Medicinal Plant/Ministry of Forest. Technical experts for formulation of medicine, pharmacists, under the research laboratory were shifted to Royal Drugs Limited for production and quality...

Learn More

बढुवा सिफारिस गरिएको सम्बन्धी सूचना

बढुवा सिफारिस गरिएको सम्बन्धी सूचना

हेमोडायलिसिसको बिक्री बितरण शुरु

मिति २०८०-०७-१३ गते बाट नयाँ प्रोडक्ट "हेमोडायलिसिस" को बिक्री बितरण...

अर्थ मन्त्रालयबाट तोकिनु भएका प्रतिनिधि संचालक श्री सुनिल कुमार यादवको स्वागत

यस लिमिटेड संचालक समितिको ६६९ औं वैठकमा समितिका तर्फबाट अध्यक्ष...

Message from General Manager

MR. KAILASH KUMAR PANERU

For 50 years now, NAL has built a unique position in the Nepalese healthcare system. In the field of pharmaceutics, and I am pleased to play a part as General Manager. One of the primary roles of pharmaceutical industry is to foster excellence in production, quality assurance and research. It is a role that we take very seriously here at NAL, reflected well in short and long term plan.

The immediate plan shall be executed to start manufacturing its popular brand Cetamol (paracetamol) tablet and Jeevan Jal (Oral Rehydration Salt). Both the products are in essential drug list and there is a good demand for general public at health post and sub health post level. For manufacturing the products, the existing tablet area will be modified; incorporating clean room concepts for maintaining class 100000 conditions at primary processing area. Quality control will be strengthened to quality assurance system in compliance with CGMP standard. Once the initial startup of the tablet section is commenced and the process is continued with additional products, the long-term master plan shall also be implemented to create additional facilities for further development.

0